Anyone know why the share price has dropped from 25 to 10.The analysis was the they just needed to announce contracts .....which they did. On same subject BRF(bright futures) have done everything they said they would do and more with an excellent recent set of results recently and there share price has halved? Maybe the explanation is if the city dont like you (or find you sexy) then they ....just dont like you!I also think these smaller companies can be very bad at managing their PR and sometimes go months without announcing any news ,which nobody likes.As you may have guessed thes ar my current golden turkeys and may be guilty of whinging!

begining to rise nicely.sentiment becomming positive as they head up from 9p or sp friday to 11.5p bid at close yesterday.

Results 20th september any thought.

possibly will state "in line with expectations" though at least we should see what the agreements with all the various Pharma's are worth.It can only be positive overall considering they almost went bust in Dec2003,since then there has been nothing but good news.

here's latest RNS, which I believe are excellent and certainly place Cyprotex on a good footing and we should now see increased momentum in the stock over the comming months.

Cyprotex PLC
20 September 2004


Press Release 20 September 2004

CYPROTEX PLC

Interim Report and Accounts for the six months ended 30 June 2004

Cyprotex PLC, a drug discovery technology and information company, today reports
its interim results for the six months ended 30 June 2004.

Highlights

Turnover up by 140% at 886,000 (369,000)
Gross profit 185% higher at 734,000 (257,000)
Pre-tax loss over 22% lower at 832,000 (1.08 million)
Placing of 2.94 million (net of expenses) at beginning of period leaves
cash balances at 2.7 million (868,000)
Customer portfolio expanded to 25 major companies including revenue
generating contracts with Roche, AstraZeneca, Altana and Solvay
Contractual discussions well advanced with further blue-chip pharmaceutical
and biotechnology companies.

Commenting on the results, Robert Atwater, Chairman of Cyprotex PLC, said:

'Cyprotex has established a unique position in the world of drug discovery, and
with our innovative approach and focus on further improving operational
efficiencies remaining the same, management is now confident of achieving the
financial goals it set itself at the start of 2004.'


For further information, please contact:
Cyprotex PLC
Robert M. Atwater, Chairman Tel: +44 (0) 1625 505 100

director buy by Attwater of 100000 shares thoughts anyone

rapid lift on bid.Reasons?

Robert Atwater bought a further 240,000 shares at 9.84p on the 3rd December.

I dipped my toe in and bought 16,000 at 10.85p on the 6th.